Biomedical subjects

B R Crane

Publications and source records attributed to B R Crane.

25 records · Page 2Linked to original sources

PubMed1997

Multiwavelength anomalous diffraction of sulfite reductase hemoprotein: making the most of MAD data.

The structure of the 60 kDa E. coli sulfite reductase hemoprotein (SiRHP) was determined by using multiwavelength anomalous diffraction (MAD) to exploit the relatively small anomalous signals produced near the Fe K absorption edge from the protein's native Fe(4)S(4) cluster and siroheme Fe atom. Because of systematic measurement error, generation of useful MAD data required rejection of outlying intensity observations that were only identified by careful manual scrutiny of the observed intensities and single parameter scaling among wedges of diffraction data. The key steps for obtaining effective phases were local anisotropic scaling between Bijvoet pairs and among wavelengths, extraction of phase information from unmerged observations, and refinement of the anomalous scattering model. Important factors for positioning the anomalous scattering model included removal of aberrant coefficients from Patterson syntheses, positional refinement of the Fe positions against MAD-derived normal-scattering amplitudes, and systematic searches of cluster orientation that attempted to optimize agreement between observed and calculated MAD intensities. To obtain MAD phases for reflections that were underdetermined for least-squares methods, parameters necessary for defining phase-probability distributions had to be estimated from the anomalous scattering model. The MAD phase distributions, when combined probabilistically with otherwise insufficient MIR phase information, led to the determination of the SiRHP structure. The techniques developed and lessons learned from the SiRHP MAD experiment should be applicable to the design of MAD experiments on other macromolecules.

Journal Article↗

PubMed1997

Determining phases and anomalous-scattering models from the multiwavelength anomalous diffraction of native protein metal clusters. improved MAD phase error estimates and anomalous-scatterer positions.

A strategy is presented for refining anomalous scattering models and calculating protein phases directly from the Bijvoet and dispersive differences of a macromolecular multiwavelength anomalous diffraction (MAD) experiment. This procedure, incorporated in the program MADPHSREF, is especially amenable for exploiting the weak perturbations to normal scattering produced by inner-shell electronic transitions of asymmetric metal and protein ligand assemblies. The protocol accounts for more than one type of anomalous scatterer, incorporates stereochemical restraints, treats the data in local scaling groups, and partly compensates for correlated errors. Approximating maximum likelihood by averaging observation variances and covariances over all values of phase considerably improved error estimation. Probabilistic rejection of aberrant observations, re-evaluated before each refinement cycle, improved refinement convergence and accuracy compared with other less flexible rejection criteria. MADPHSREF allows the facile combination of MAD phase information with phase information from other sources. For the suifite reductase hemoprotein (SiRHP), relative weights for MAD and multiple isomorphous replacement (MIR) phases were determined by matching histograms of electron density. Accurate metal-cluster geometries and the associated errors in atomic positions can be determined from refinement against anomalous differences using normal scattering phases from a refined structure. When applied to MAD data collected on SiRHP, these methods confirmed the Fe(4)S(4) cluster asymmetry initially observed in the refined 1.6 A resolution structure and resulted in a MAD-phased, experimental, electron-density map that is of better quality than the combined MAD/MIR map originally used to determine the structure.

Journal Article↗

PubMed1996

Unusual trigonal-planar copper configuration revealed in the atomic structure of yeast copper-zinc superoxide dismutase.

The three-dimensional structure of yeast copper-zinc superoxide dismutase (CuZnSOD) has been determined in a new crystal form in space group R32 and refined against X-ray diffraction data using difference Fourier and restrained crystallographic refinement techniques. The unexpected result is that the copper ion has moved approximately 1 angstrom from its position in previously reported CuZnSOD models, the copper-imidazolate bridge is broken, and a roughly trigonal planar ligand geometry characteristic of Cu(I) rather than Cu(II) is revealed. Final R values for the two nearly identical room temperature structures are 18.6% for all 19 149 reflections in the 10.0-1.7 angstrom resolution range and 18. 2% for 17 682 reflections (F > 2 sigma) in the 10.0-1.73 angstrom resolution range. A third structure has been determined using X-ray data collected at -180 degrees C. The final R value for this structure is 19.0% (R(free) = 22.9%) for all 24 356 reflections in the 10.0-1.55 angstrom resolution range. Virtually no change in the positions of the ligands to the zinc center is observed in these models. The origin of the broken bridge and altered Cu-ligand geometry is discussed.

Crystallography, X-Ray↗

PubMed1996

The relationship between structure and function for the sulfite reductases.

The six-electron reductions of sulfite to sulfide and nitrite to ammonia, fundamental to early and contemporary life, are catalyzed by diverse sulfite and nitrite reductases that share an unusual prosthetic assembly in their active centers, namely siroheme covalently linked to an Fe4S4 cluster. The recently determined crystallographic structure of the sulfite reductase hemoprotein from Escherichia coli complements extensive biochemical and spectroscopic studies in revealing structural features that are key for the catalytic mechanisms and in suggesting a common symmetric structural unit for this diverse family of enzymes.

Amino Acid Sequence↗

PubMed1995

Sulfite reductase structure at 1.6 A: evolution and catalysis for reduction of inorganic anions.

Fundamental chemical transformations for biogeochemical cycling of sulfur and nitrogen are catalyzed by sulfite and nitrite reductases. The crystallographic structure of Escherichia coli sulfite reductase hemoprotein (SiRHP), which catalyzes the concerted six-electron reductions of sulfite to sulfide and nitrite to ammonia, was solved with multiwavelength anomalous diffraction (MAD) of the native siroheme and Fe4S4 cluster cofactors, multiple isomorphous replacement, and selenomethionine sequence markers. Twofold symmetry within the 64-kilodalton polypeptide generates a distinctive three-domain alpha/beta fold that controls cofactor assembly and reactivity. Homology regions conserved between the symmetry-related halves of SiRHP and among other sulfite and nitrite reductases revealed key residues for stability and function, and identified a sulfite or nitrite reductase repeat (SNiRR) common to a redox-enzyme superfamily. The saddle-shaped siroheme shares a cysteine thiolate ligand with the Fe4S4 cluster and ligates an unexpected phosphate anion. In the substrate complex, sulfite displaces phosphate and binds to siroheme iron through sulfur. An extensive hydrogen-bonding network of positive side chains, water molecules, and siroheme carboxylates activates S-O bonds for reductive cleavage.

Amino Acid Sequence↗

PubMed1992

Proton uptake accompanies formation of the ternary complex of citrate synthase, oxaloacetate, and the transition-state analog inhibitor, carboxymethyl-CoA. Evidence that a neutral enol is the activated form of acetyl-CoA in the citrate synthase reaction.

Citrate synthase complexes with the transition-state analog inhibitor, carboxymethyl-CoA (CM-CoA), are believed to mimic those with the activated form of acetyl-CoA. The X-ray structure [Karpusas, M., Branchaud, B., & Remington, S.J. (1990) Biochemistry 29, 2213] of the ternary complex of the enzyme, oxaloacetate, and CMCoA has been used as the basis for a proposal that a neutral enol of acetyl-CoA is that activated form. Since the inhibitor carboxyl has a pKa of 3.90, analogy with an enolic acetyl-CoA intermediate leads to the prediction that a proton should be taken up from solution upon formation of the analog complex so that the transition-state analog carboxyl is protonated when bound. We have obtained evidence in solution for this proposal by comparing the isoelectric points and the pH dependence of the dissociation constants of the ternary complexes of the pig heart enzyme with the neutral ground-state analog inhibitor, acetonyl-CoA (KCoA), and the anionic transition-state analog inhibitor (CMCoA) and by studying the NMR spectra of the transition-state analog complexes of allosteric (Escherichia coli) and nonallosteric (pig heart) enzymes. The pH dependence of the dissociation constant of the ground-state analog indicates no proton uptake, while that for the transition-state analog indicates that 0.55 +/- 0.04 proton is taken up when the analog binds to the citrate synthase-oxaloacetate binary complex. The overall charges of ternary complexes of the pig heart enzyme with the transition-state and ground-state analog inhibitors are the same, as monitored by their isoelectric points.(ABSTRACT TRUNCATED AT 250 WORDS)

Acetyl Coenzyme A↗

PubMed1991

The role of cysteine 206 in allosteric inhibition of Escherichia coli citrate synthase. Studies by chemical modification, site-directed mutagenesis, and 19F NMR.

Escherichia coli citrate synthase is strongly and specifically inhibited by NADH, but this inhibition can be prevented by reacting the enzyme with Ellman's reagent. We have now labeled the single reactive cysteine covalently with monobromobimane and isolated and sequenced the bimane-containing cyanogen bromide peptide and identified the cysteine as Cys-206. Modeling studies suggest that this residue is on the subunit surface, 25-30 A from the active site. Mutation of Cys-206 to serine (C206S), or of Gly-207 to alanine (E207A), weakened NADH binding and inhibition; when these mutations were present together, NADH binding was weaker by 18-fold and inhibition by 250-fold. The mutations also had small effects on substrate binding at the active site. Cys-206 of wild type enzyme and of the mutant E207A was alkylated with 1,1,1-trifluorobromoacetone and the environment of the fluorine nuclei studied by 19F NMR. With wild type enzyme, the NMR spectrum consisted of two peaks of about equal intensity but different line widths, at -8.65 ppm (line width 11.2 +/- 0.5 Hz) and -7.6 ppm (line width 57 +/- 4 Hz). As the labeled wild type citrate synthase was titrated with KCl, the narrow peak converted to the broad one. The same range of KCl concentrations was needed for this conversion as for the allosteric activation of E. coli citrate synthase. The E207A mutant gave the broader NMR peak almost exclusively. We propose that the fluorine label in wild type citrate synthase exists in two conformational states with different mobilities, exchanging slowly on the NMR time scale, and that treatment with KCl, or truncation of the Glu-207 side chain by mutagenesis, stabilizes one of these states. Consistent with this explanation is the finding that Cys-206 reacts more quickly with Ellman's reagent in the presence of KCl, and that this rate is faster yet in the E207A mutant.

Alkylation↗